Antegrade embolization of spontaneous splenorenal shunt for post–transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy
Mehul Doshi, Keith Pereira, Andres Carrion, Paul Martin – 13 November 2015
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis
Robert S. Brown, Brian J. McMahon, Anna S.F. Lok, John B. Wong, Ahmed T. Ahmed, Mohamed A. Mouchli, Zhen Wang, Larry J. Prokop, Mohammad Hassan Murad, Khaled Mohammed – 13 November 2015 – Perinatal or mother‐to‐child transmission (MTCT) of hepatitis B virus (HBV) remains the major risk factor for chronic HBV infection worldwide. In addition to hepatitis B immune globulin and vaccination, oral antiviral therapies in highly viremic mothers can further decrease MTCT of HBV.
AASLD practice guidelines: The past, the present, and the future
Raphael B. Merriman, Tram T. Tran – 13 November 2015
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault, Natalie H. Bzowej, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, M. Hassan Murad – 13 November 2015
Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down‐staging?
Francis Y. Yao, Nicholas Fidelman – 11 November 2015 – Down‐staging of hepatocellular carcinoma prior to liver transplantation (LT) has generated a lot of interest in recent years and has been identified in two recent national conferences on hepatocellular carcinoma as one of the priorities for research. Down‐staging is defined as reduction in the tumor burden using local regional therapy specifically to meet acceptable criteria for LT.
Care delivery and outcomes among US veterans with hepatitis B: A national cohort study
Marina Serper, Gina Choi, Kimberly A. Forde, David E. Kaplan – 11 November 2015 – Previous studies have identified gaps in hepatitis B care. The objectives of this study were to evaluate the delivery of care among a national cohort of US veterans with chronic hepatitis B infection and examine risk factors for adverse clinical outcomes.
A faithful JAGGED1 haploinsufficiency mouse model of arteriohepatic dysplasia (Alagille syndrome) after all
Stacey S. Huppert – 11 November 2015
Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down‐staging?
Francis Y. Yao, Nicholas Fidelman – 11 November 2015 – Down‐staging of hepatocellular carcinoma prior to liver transplantation (LT) has generated a lot of interest in recent years and has been identified in two recent national conferences on hepatocellular carcinoma as one of the priorities for research. Down‐staging is defined as reduction in the tumor burden using local regional therapy specifically to meet acceptable criteria for LT.
Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy‐proven nonalcoholic fatty liver disease: A prospective study
Jeffrey Cui, Elhamy Heba, Carolyn Hernandez, William Haufe, Jonathan Hooker, Michael P. Andre, Mark A. Valasek, Hamed Aryafar, Claude B. Sirlin, Rohit Loomba – 11 November 2015 – Magnetic resonance elastography (MRE), an advanced magnetic resonance–based imaging technique, and acoustic radiation force impulse (ARFI), an ultrasound‐based imaging technique, are accurate for diagnosing nonalcoholic fatty liver disease (NAFLD) fibrosis. However, no head‐to‐head comparisons between MRE and ARFI for diagnosing NAFLD fibrosis have been performed.